JAMA Online First: Trial of Remdesivir for COVID-19

Trouble viewing this email?

Online First

AUGUST 21, 2020

ORIGINAL INVESTIGATION

Christoph D. Spinner, MD; Robert L. Gottlieb, MD, PhD; Gerard J. Criner, MD; et al.

Editorial: ; Erin K. McCreary, PharmD; Derek C. Angus, MD, MPH

EDITORIAL

Erin K. McCreary, PharmD; Derek C. Angus, MD, MPH

JAMA PATIENT PAGE

Joseph Hadaya, MD; Peyman Benharash, MD

TRENDING NOW ON JAMA

Thank you for subscribing to JAMA Network email alerts. This message was sent to [email protected] by [email protected].

To sign up for additional alerts, or to unsubscribe, .

To ensure you always receive JAMA Network emails, add the email address [email protected] to your address book.

To unsubscribe by mail, contact:

JAMA Network
AMA Plaza
330 N Wabash Ave
Chicago, IL 60611
Or call (800) 621-8335.

Other library

JAMA Online First ( 13:28 - 04/01/2024 )
New Issue: Prone ECMO for ARDS, Fluvoxamine for COVID-19, Hepatitis D Review, and more ( 10:59 - 27/12/2023 )
JAMA Internal Medicine - Most Viewed Articles 2023 ( 08:33 - 21/12/2023 )
Get Your End of Year CME ( 09:12 - 13/12/2023 )
JAMA Internal Medicine: New Issue September 2023 ( 16:38 - 07/09/2023 )
New Issue: BP Targets After Stroke Thrombectomy, Psilocybin for Depression, Large Language Models in Medicine, and more ( 16:37 - 07/09/2023 )
JAMA Network Open: New Issue ( 16:36 - 07/09/2023 )
JAMA Dermatology Online First ( 16:34 - 07/09/2023 )
JAMA Dermatology Online First AUGUST 16, 2023 ( 16:33 - 07/09/2023 )
JAMA Dermatology Online First AUGUST 9, 2023 ( 16:33 - 07/09/2023 )